Overview
A long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation.
Indication
For the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Associated Conditions
- Bronchial Asthma
- Bronchospasm
- Chronic Bronchitis
- Emphysema
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/04/04 | Phase 4 | Completed | |||
2015/01/29 | Not Applicable | UNKNOWN | |||
2014/06/17 | Phase 1 | Completed | |||
2010/07/27 | Phase 4 | UNKNOWN | Shanghai Jiao Tong University School of Medicine | ||
2010/03/29 | Phase 3 | Completed | Taiwan Otsuka Pharm. Co., Ltd | ||
2010/03/24 | Phase 4 | Completed | |||
2010/02/26 | Phase 3 | Completed | Taiwan Otsuka Pharm. Co., Ltd | ||
2006/11/01 | Phase 4 | Terminated |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Procaterol Hydrochloride Granules | 国药准字H20243643 | 化学药品 | 颗粒剂 | 4/30/2024 | |
| Procaterol Hydrochloride Granules | 国药准字H20041825 | 化学药品 | 颗粒剂 | 7/15/2023 | |
| Procaterol Hydrochloride Granules | 国药准字H20254102 | 化学药品 | 颗粒剂 | 5/13/2025 | |
| Procaterol Hydrochloride Capsules | 国药准字H20020464 | 化学药品 | 胶囊剂 | 4/20/2020 | |
| Procaterol Hydrochloride Capsules | 国药准字H20000413 | 化学药品 | 胶囊剂 | 4/26/2020 | |
| Procaterol Hydrochloride Inhalation Solution | 国药准字H20244541 | 化学药品 | 吸入制剂 | 7/30/2024 | |
| Procaterol Hydrochloride Inhalation Solution | 国药准字H20253558 | 化学药品 | 吸入制剂 | 3/4/2025 | |
| Procaterol Hydrochloride Inhalation Solution | 国药准字H20253559 | 化学药品 | 吸入制剂 | 3/4/2025 | |
| Procaterol Hydrochloride Inhalation Solution | 国药准字H20249447 | 化学药品 | 吸入制剂 | 11/22/2024 | |
| Procaterol Hydrochloride Inhalation Solution | 国药准字H20253327 | 化学药品 | 吸入制剂 | 1/24/2025 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| BF-PROCATEROL HYDROCHLORIDE SYRUP 5MCG/ML | N/A | bright future pharmaceuticals factory o/b bright future pharmaceutical laboratories limited | N/A | N/A | 9/11/2024 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.